Rostock University Medical Center

Research site

Germany Nr. 05, Suedring 75, Suedstadt, 18059 Rostock, Germany

Non-small cell lung cancer
Adult patients

About Specializations

Rostock University Medical Center in Rostock, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, and other specialisations. This site conducts important research.

Non-small cell lung cancer

Main research areas of the site

Individualized Immunotherapy for Early-Stage Unfavorable Classical Hodgkin Lymphoma

The department is evaluating a PET‑guided approach that adds checkpoint inhibition to first‑line therapy, aiming for effective and tolerable treatment.

PET‑guided treatment planning
Checkpoint inhibitor tislelizumab
One‑year progression‑free survival assessment
Patient‑centered therapy design

Research is conducted at Rostock University Medical Center, focusing on innovative strategies for neoplasms.

Targeted Radiation and Immunotherapy for Brain Metastases in NSCLC

A trial investigates whether stereotactic radiosurgery to all brain lesions followed by ivonescimab plus chemotherapy improves intracranial disease control.

SRS/FSRT to multiple metastases
Combination with immunotherapy
Intracranial progression‑free survival measurement
Management of asymptomatic brain metastases

The study, led by the same oncology team at Rostock University Medical Center, addresses advanced non‑small cell lung cancer.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Nr. 05, Suedring 75, Suedstadt18059 RostockGermany

Open in maps ↗

Recruiting now: no trials
Conditions studied: 1

More sites in Rostock Germany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Non-small cell lung cancer

Not yet recruiting

Ivonescimab with drug combination in patients with asymptomatic brain metastases from non‑small cell lung cancer – randomized phase II trial

Registered drugNo placebo

Ivonescimab with drug combination in patients with asymptomatic brain metastases from non‑small cell lung cancer – randomized phase II trial

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dacarbazine
Sponsor:University Of Cologne

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites